Clinical Trial

Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak

Study acronym: ENDO-VAL
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to assess the impact of endoscopic vacuum therapy in patients who underwent total gastrectomy due to gastric cancer and developed esophago-jejunal anastomotic leakage. The main outcomes to be investigated are the following: Primary endpoint: mortality rate Secondary endpoints: morbidity rate, time from AL diagnosis to discharge, patients satisfactory rate.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-07.
Trial Details
NCT Number NCT07295236
Lead Sponsor Ukrainian Society of Clinical Oncology
Conditions Esophagojejunal Anastomotic Leak
Enrollment 100 participants
Start Date 2025-12-01
Primary Completion 2030-12-01 (estimated)
Study Completion 2035-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-29